Evaluation of the Effectiveness of an Accelerated Rehabilitation Protocol Based on Multimodal Analgesia Optimization for Uni-compartmental Knee Prosthesis Surgery
APUC
1 other identifier
observational
200
1 country
1
Brief Summary
Today, prosthetic replacement for osteoarthritis of the knee is a frequent surgery. In France, nearly 100,000 knee arthroplasties are performed each year . Over the last two decades, there has been growing interest in performing single compartment knee replacement (SKR) surgery in patients with isolated single compartment osteoarthritis. The explanation lies in faster recovery, less postoperative pain and less morbidity compared to total knee arthroplasty (TKR) . Pain control is one of the major elements of outpatient management of CKD . Prosthetic knee surgery is very painful, the median pain is rated at 5 out of 10 and on average we use 32 milligrams of morphine . The efficiency of the adductor canal block is effective in this context, it avoids the motor block obtained by the femoral block, therefore interesting for ambulatory management in view of a resumption of the fast walking foreseen for the patient. The IPACK (interspace between popliteal artery and the capsule posterior knee) is designed to block the small sensory branches of the sciatic nerve that pass through this space without affecting the motor components. The IPACK block provides analgesia only for the posterior knee and would probably be ineffective alone for postoperative analgesia It is therefore often performed with an adductor canal block for multimodal analgesia. This block is performed in several facilities, and data are increasingly emerging on its effectiveness . Thus, based on the recommendations of the French Society of Anesthesia and Resuscitation, on improved rehabilitation after heavy orthopedic surgery on the lower limb published in 2019 the objective of this study is to evaluate the relevance of a protocol concerning prosthetic knee replacement (PUC) in ambulatory care, based on optimized pain control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2021
CompletedFirst Submitted
Initial submission to the registry
January 26, 2021
CompletedFirst Posted
Study publicly available on registry
June 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2022
CompletedJune 7, 2021
January 1, 2021
1.1 years
January 26, 2021
June 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Test get up and go test measured from day 0 to day 3. The test is successful if the score is >1
Day 0 to Day 3
Secondary Outcomes (3)
evaluation of the patient's recovery by the QOR-15 questionnaire at 24 and 48 hours,
24 and 48 hours
evaluation of visual analogue pain scale up to Day 5 postoperatively
day 5
evaluation of morphine consumption up to Day 5 postoperatively
day 5
Eligibility Criteria
Patients with programmed SKR
You may qualify if:
- Patients with programmed SKR,
- \>18 and \< 85 years of age,
- Score ASA 1-2,
- No cognitive impairment,
- No thromboembolic TCDA,
- Without CI to local anesthetics, analgesics,
- Accepting outpatient care
- No opposition formulated
You may not qualify if:
- \<18 years and \>85 years
- Patients under legal protection (guardianship, curatorship, ...)
- Refusal to participate
- Support for a total knee prosthesis,
- Emergency surgery or revision surgery,
- ASA3-4,
- SAOS not fitted,
- Allergy or hypersensitivity to local anesthetics,
- Outpatient discharge criteria not met.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Brest
Brest, 29609, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2021
First Posted
June 7, 2021
Study Start
January 7, 2021
Primary Completion
January 31, 2022
Study Completion
January 31, 2022
Last Updated
June 7, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning one year and ending five years following the publication
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.
All collected data that underlie results in a publication